Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

3D cell culture is a man-made environment in which cells interact with the surroundings in all three dimensions. Cells grown in 3D cell culture exhibit similar properties of cells found inside living organisms in terms of cellular characteristics and behavior.

Statistics:

The global 3D cell culture market is estimated to account for US$ 16,270.5 Mn in terms of value by the end of 2027.

Global 3D Cell Culture Market: Drivers

High prevalence of cancer is expected to propel growth of the global 3D cell culture market over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Moreover, R&D in 3D cell culture is also expected to aid in growth of the global 3D cell culture market. For instance, in August 2020, researchers at Okayama University created a new 3D cell culture model of pancreatic cancer that closely mimics the "fibrotic" tissue characteristically observed in patients.

Statistics:

North America held dominant position in the global 3D cell culture market in 2019, accounting for 38.8% share in terms of volume, followed by Europe and Asia Pacific, respectively.

Figure 1: Global 3D Cell Culture Market Share (%) Value, By Region, 2019

3D Cell Culture  | Coherent Market Insights

Global 3D Cell Culture Market: Restraints

Lack of consistency in products is expected to hinder growth of the global 3D cell culture market. The lack of consistency between wells and batches of cell culture are the other major barriers in the adoption of 3D cell culture techniques. Researchers face severe problems while inserting scaffold/ECM into microplate wells. This inconsistency in the products reduces the reproducibility of results and, thus, reduces the efficiency of the research. In addition, matrices made from animal tissues may contain unwanted growth factors and viruses, which could adversely affect the cell culture productivity and reproducibility.

Moreover, lack of skilled professionals and budget restrictions for research-related activities is also expected to hinder the market growth.

request-sample

3D Cell Culture Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 2,093.7 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 29.1% 2027 Value Projection: US$ 16,270.5 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
  • Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: North Africa, Central Africa, South Africa
Segments covered:
  • By Technology: Extracellular Matrices or Scaffolds, Bioreactors, Gels, Scaffold-free platforms, Microchips.
  • By Application: Research, Drug Discovery, Tissue Engineering, Clinical Applications, Stem Cell Biology.
  • By End User: Research Labs & Institutes, Biopharmaceutical Industry, Hospitals and diagnostic centers, Others.
Companies covered:

Becton, Dickinson and Company, Lonza Group, Thermo Fisher Scientific, Inc., Corning Incorporated, 3D Biotek LLC, 3D Biomatrix, Inc., Global Cell Solutions, Inc., InSphero AG, Sigma-Aldrich Corporation (a subsidiary of Merck KGaA), and Reinnervate Ltd. (a subsidiary of ReproCELL)

Growth Drivers:
  • Increasing prevalence of cancer
  • Approval and launch of new products
Restraints & Challenges:
  • Lack of skilled professionals

Global 3D Cell Culture Market: Opportunities 

Use of microfluidic technology is expected to offer lucrative growth opportunities for players in the global 3D cell culture market. The microfluidic technology has opened an array of opportunities for the 3D cell culture market by developing a platform that can produce a cell culture model, which mimics human organs. The microfluidic technology has various advantages over the traditional method. Microfluidic devices can generate complex dynamic micro-scale environments that resemble in-vivo environments. It reduces the cost of drug discovery by lowering the requirement of samples and reagents.

Moreover, efficacy of 3D cell culture systems over traditional 2D monolayer systems is also expected to aid in growth of the global 3D cell culture market. For instance, in August 2020, a new paper exploring the application of patient-derived organoids (PDOs) published in the journal PLOS ONE reported that 3D cell culture systems reveal drug efficacy previously undetectable in traditional 2D monolayer systems.

Statistics:

The global 3D cell culture market was valued at US$ 2,093.7 Mn in 2019 and is forecast to reach a value of US$ 16,270.5 Mn by 2027 at a CAGR of 29.1% between 2020 and 2027.

Figure 2: Global 3D Cell Culture Market Value (US$ Mn), 2016 – 2027

3D Cell Culture  | Coherent Market Insights

Market Trends/Key Takeaways

Increasing adoption of 3D cell culture systems is expected to propel growth of the global 3D cell culture market. For instance, in September 2020, MBC BioLabs added a state-of-the-art Leica THUNDER 3D Assay Imager to provide advanced research microscopy capabilities to their members.

Major players in the global 3D cell culture market are focused on adopting partnership strategies to enhance their market share. For instance, in August 2020, Corning Incorporated entered into a supply agreement with BioSurfaces, LLC, under which Corning will supply its Transwell permeable supports plates to BioSurfaces. 

Global 3D Cell Culture Market: Competitive Landscape

Major players operating in the global 3D cell culture market include, Becton, Dickinson and Company, Corning Incorporated, Lonza Group, Thermo Fisher Scientific, Inc.,  3D Biotek LLC, 3D Biomatrix, Inc., Global Cell Solutions, Inc., InSphero AG, Sigma-Aldrich Corporation (a subsidiary of Merck KGaA), and Reinnervate Ltd. (a subsidiary of ReproCELL).

Global 3D Cell Culture Market: Key Developments

Major players in the global 3D cell culture market are focused on adopting partnership strategies to enhance their market share. For instance, in June 2020, Lonza Group partnered with the Sweden-based company CELLINK to offer a comprehensive 3-dimensional (3D) bioprinting solution designed to optimize and increase access to complete 3D cell culture workflows.

3D cell culture refers to the process of growing cells in their native context or in vivo environment. Cells grown in 3D cell culture exhibit similar properties of cells found inside living organisms in terms of cellular characteristics and behavior. High prevalence of cancer along with increasing investment in research and development is expected to propel the market growth during the forecast period. Moreover, increasing focus on regenerative medicines is also expected to offer lucrative growth opportunities for players in the global 3D cell culture market.

Key features of the study:

  • This report provides in-depth analysis of the Global 3D Cell Culture market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global 3D Cell Culture market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Becton, Dickinson and Company, Lonza Group, Thermo Fisher Scientific, Inc., Corning Incorporated, 3D Biotek LLC, 3D Biomatrix, Inc., Global Cell Solutions, Inc., InSphero AG, Sigma-Aldrich Corporation (a subsidiary of Merck KGaA), and Reinnervate Ltd. (a subsidiary of ReproCELL).
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global 3D Cell Culture market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global 3D Cell Culture market

Detailed Segmentation:

  • Global 3D Cell Culture Market, By Technology:
    • Extracellular Matrices or Scaffolds
    • Bioreactors
    • Gels
    • Scaffold-free platforms
    • Microchips
  • Global 3D Cell Culture Market, By Application:
    • Research
    • Drug Discovery
    • Tissue Engineering
    • Clinical Applications
    • Stem Cell Biology
  • Global 3D Cell Culture Market, By End User:
    • Research Labs & Institutes
    • Biopharmaceutical Industry
    • Hospitals and diagnostic centers
    • Others
  • Global 3D Cell Culture Market, By Region:
    • North America
      • By Technology:
        • Extracellular Matrices or Scaffolds
        • Bioreactors
        • Gels
        • Scaffold-free platforms
        • Microchips
      • By Application
        • Research
        • Drug Discovery
        • Tissue Engineering
        • Clinical Applications
        • Stem Cell Biology
      • By End User
        • Research Labs & Institutes
        • Biopharmaceutical Industry
        • Hospitals and diagnostic centers
        • Others
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Technology:
        • Extracellular Matrices or Scaffolds
        • Bioreactors
        • Gels
        • Scaffold-free platforms
        • Microchips
      • By Application
        • Research
        • Drug Discovery
        • Tissue Engineering
        • Clinical Applications
        • Stem Cell Biology
      • By End User
        • Research Labs & Institutes
        • Biopharmaceutical Industry
        • Hospitals and diagnostic centers
        • Others
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Technology:
        • Extracellular Matrices or Scaffolds
        • Bioreactors
        • Gels
        • Scaffold-free platforms
        • Microchips
      • By Application
        • Research
        • Drug Discovery
        • Tissue Engineering
        • Clinical Applications
        • Stem Cell Biology
      • By End User
        • Research Labs & Institutes
        • Biopharmaceutical Industry
        • Hospitals and diagnostic centers
        • Others
      • By Country
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Technology:
        • Extracellular Matrices or Scaffolds
        • Bioreactors
        • Gels
        • Scaffold-free platforms
        • Microchips
      • By Application
        • Research
        • Drug Discovery
        • Tissue Engineering
        • Clinical Applications
        • Stem Cell Biology
      • By End User
        • Research Labs & Institutes
        • Biopharmaceutical Industry
        • Hospitals and diagnostic centers
        • Others
      • By Country
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Technology:
        • Extracellular Matrices or Scaffolds
        • Bioreactors
        • Gels
        • Scaffold-free platforms
        • Microchips
      • By Application
        • Research
        • Drug Discovery
        • Tissue Engineering
        • Clinical Applications
        • Stem Cell Biology
      • By End User
        • Research Labs & Institutes
        • Biopharmaceutical Industry
        • Hospitals and diagnostic centers
        • Others
      • By Country
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • By Technology:
        • Extracellular Matrices or Scaffolds
        • Bioreactors
        • Gels
        • Scaffold-free platforms
        • Microchips
      • By Application
        • Research
        • Drug Discovery
        • Tissue Engineering
        • Clinical Applications
        • Stem Cell Biology
      • By End User
        • Research Labs & Institutes
        • Biopharmaceutical Industry
        • Hospitals and diagnostic centers
        • Others
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Becton, Dickinson and Company *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Lonza Group
    • Thermo Fisher Scientific, Inc.
    • Corning Incorporated
    • 3D Biotek LLC
    • 3D Biomatrix, Inc.
    • Global Cell Solutions, Inc.
    • InSphero AG
    • Sigma-Aldrich Corporation (a subsidiary of Merck KGaA)
    • Reinnervate Ltd. (a subsidiary of ReproCELL)
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
    • COVID19 Impact on the market
  4. Global 3D Cell Culture Market, By Technology, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Extracellular Matrices or Scaffolds
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Bioreactors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Gels
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Scaffold-free platforms
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Microchips
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global 3D Cell Culture Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Research
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Drug Discovery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Tissue Engineering
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Clinical Applications
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Stem Cell Biology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global 3D Cell Culture Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Research Labs & Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Biopharmaceutical Industry
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Hospitals and diagnostic centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global 3D Cell Culture Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Company Profiles
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cardinal Health Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Lonza Group
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Thermo Fisher Scientific, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • 3D Biotek LLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • 3D Biomatrix, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Global Cell Solutions, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • InSphero AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sigma-Aldrich Corporation (a subsidiary of Merck KGaA)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Reinnervate Ltd. (a subsidiary of ReproCELL)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 22 market data tables and 14 figures on “3D Cell Culture Market - Global forecast to 2027”.

Frequently Asked Questions

The Global 3D Cell Culture market size was valued at US$ 2,093.7 million in 2019 and is estimated to exhibit a CAGR of 29.1% between 2020 and 2027.
Extracellular Matrices or Scaffolds segment held the major market share in 2019 owing to technological advancement in product design and increasing product approvals is expected to propel growth of the market
Major factor driving the growth of Global 3D Cell Culture market during the forecast period increasing prevalence of chronic diseases, increasing research & development , and adoption of expansion strategies from major companies.
Major factors hampering the growth of the Global 3D Cell Culture market during the forecast period constitutes of lack of reimbursement.
North America market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Becton, Dickinson and Company, Corning Incorporated, Lonza Group, Thermo Fisher Scientific, Inc., 3D Biotek LLC, 3D Biomatrix, Inc., Global Cell Solutions, Inc., InSphero AG, Sigma-Aldrich Corporation (a subsidiary of Merck KGaA), and Reinnervate Ltd. (a subsidiary of ReproCELL)
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner